2m 2m 2m 2m 2m 2m 2m
CUE BIOPHARMA (CUE)
NASDAQ
$28.59-$0.15 (-0.52%)
Price as of Sep 11, 2026 7:30 PM EDT- $208.8MMarket Cap
- 29.20%1-Year Change
- BiotechnologyIndustry
CUE BIOPHARMA (CUE)
$28.59-$0.15 (-0.52%)
CUE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $28.74 | ||
Change | +$0.74 (+2.64%) | ||
Open | $28.38 | ||
High | $28.89 | ||
Low | $27.50 | ||
Previous Close | $28.00 | ||
Volume | 122,768 | ||
30-Day Average Volume | 169,716 | ||
1-Week Change | 4.74% | ||
1-Month Change | 1.77% | ||
1-Year Change | 29.20% | ||
3-Year Change | -64.39% | ||
5-Year Change | -91.94% | ||
Fundamentals | |||
Shares Outstanding | 7.3M | ||
Total Assets | $30.7M | ||
Market Cap | $208.8M | ||
Enterprise Value | $201.4M | ||
Period: QTR TTM FY | |||
Revenue | $7.9M | ||
Net Income | -$153.1M | ||
Free Cash Flow | -$29.0M | ||
EBIT | -$153.1M | ||
EBITDA | -$153.0M | ||
Net Working Capital | $5.4M | ||
EPS | -$24.14 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | 26 | ||
P/B | 90 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 04/24/2026 | ||
Earnings & Revenue